Inactive Instrument

Press Releases IVERIC bio, Inc.

Equities

ISEE

US46583P1021

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Iveric Bio - Astellas Receives Permanent J-code for IZERVAY for Geographic Atrophy	03-27	AQ
Loan for Acquisition of U.S. Ophthalmic R&D Company IVERIC bio, Inc. by Astellas Pharma Inc	29/09/23	AQ
Two-time Emmy Award-Winning Actor, Eric Stonestreet, Partners with Iveric Bio to Raise Awareness of Geographic Atrophy	21/09/23	AQ
Astellas Pharma Inc. - European Medicines Agency Accepts Iveric Bio's Marketing Authorization Application for Avacincaptad Pegol for Geographic Atrophy	18/08/23	AQ
Astellas Completes Acquisition of Iveric Bio	12/07/23	PR
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05/07/23	BU
IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE	15/06/23	BU
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	05/06/23	AQ
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	02/06/23	BU
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	24/05/23	BU
IVERIC bio: Q1 Earnings Snapshot	11/05/23	AQ
IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE	02/05/23	BU
Astellas to accelerate ocular disease treatments with $5.9 billion acquisition	02/05/23	AQ
Kyodo News Digest: May 1, 2023 -3-	01/05/23	AQ
IVERIC BIO, INC. : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	01/05/23	AQ
Kyodo News Digest: May 1, 2023 -2-	01/05/23	AQ
UPDATE2: Japan's Astellas to buy U.S. drugmaker Iveric Bio for $5.9 bil.	01/05/23	AQ
UPDATE1: Japan's Astellas to buy U.S. drugmaker Iveric Bio for $5.9 bil.	01/05/23	AQ
Japan's Astellas to buy U.S. drugmaker Iveric Bio for $5.9 bil.	01/05/23	AQ
Urgent Headline News	01/05/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IVERIC bio, Inc.

Equities

ISEE

US46583P1021

Press Releases

Filters